 |
benzoate/phenylacetate |
|---|---|
| Trade Name | Ammonul |
| Orphan Indication | Acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle |
| USA Market Approval | USA |
| USA Designation Date | 1993-11-22 00:00:00 |
| Sponsor | Medicis Pharmaceutical Corp.;8125 N. Hayden Road;Scottsdale, Arizona, 85258 |
